Doses of mifepristone, the abortion pill, and misoprostol, which is taken the day after to cause cramping and bleeding to empty the uterus, are pictured at a clinic in Santa Teresa, New Mexico on May 7, 2022.
'Unacceptable': Right-Wing Judge Attempts to Keep Key Abortion Pill Hearing Secret
One attorney said Judge Matthew Kacsmaryk's actions ahead of a hearing planned for Wednesday were "bordering on judicial misconduct."
Ahead of a major hearing scheduled for Wednesday in a closely watched case which could further limit abortion access across the United States, reproductive rights advocates and journalists are decrying what one attorney called a right-wing judge's "informal gag order... bordering on judicial misconduct."
U.S. District Court Judge Matthew Kacsmaryk is scheduled to preside over the first hearing in a case brought by right-wing group Alliance Defending Freedom (ADF) in Amarillo, Texas on Wednesday, with lawyers for the organization arguing that the Food and Drug Administration (FDA) should never have approved mifespristone for medication abortion use in 2000, and the U.S. Justice Department opposing that claim. ADF aims to force the FDA to revoke its approval.
As The Washington Post reported Saturday, the right-wing judge scheduled the hearing last Friday in a call with lawyers on both sides, and in what one expert called a "very irregular" move, directed the attorneys to keep the hearing under wraps in order to minimize the possibility of protests.
Kacsmaryk also said he would delay putting the hearing on the public court docket, as judges usually do to keep the public and media informed about developments. He indicated he would make the hearing public knowledge only on Tuesday evening, making it difficult for Texans and members of the media to travel to Amarillo from other parts of the state and country. The city is a five-and-a-half hour drive from Dallas, the closest major Texas city; a nearly four-hour drive from Oklahoma City; and served by few daily direct flights.
At Law Dork, journalist Chris Geidner pointed out that Kacsmaryk violated the requirements he claims to uphold in his own courtroom. The "Judge Specific Requirements" on his page at the website for the U.S. District Court for the Northern District of Texas include that Kacsmaryk "heavily disfavor[s] sealing information placed in the judicial record."
"Going further, Kacsmaryk's requirements highlight the U.S. Court of Appeals for the 5th Circuit's rulings that recognize 'the public's right to know' about what's going on in our courts, requiring litigants to explain—with signed declarations—why 'the risks of disclosure' would 'outweigh' that right of the public to know what's happening in court," noted Geidner. "In order to even consider sealing anything on his docket, Kacsmaryk requires litigants to 'explain that no other viable alternative to sealing exists.'"
Kacsmaryk said Friday on his call with the attorneys that he was requesting they keep information about the hearing secret "as a courtesy," but Geidner said on Saturday that he "in effect, if not in actuality, put a gag order on the parties."
"This is a civil case with huge national implications challenging public, some long-standing, government actions," tweeted Geidner. "The affirmative decision to hide public notification of a hearing set on Friday until Tuesday night explicitly to decrease the chances of the public learning of the hearing in an attempt to decrease public participation is so unacceptable it is simply not judicial behavior."
Following the hearing, Kacsmaryk could hand down a ruling at any time. A decision in favor of ADF would immediately force abortion clinics across the U.S. to shift to providing only surgical abortions—which account for fewer than half of abortions in the U.S. each year—or medication abortions using only misoprostol.
ADF has argued that the U.S. government ignored evidence of harmful side effects of mifepristone when it approved the drug in 2000, but medical experts say misoprostol-only abortions carry greater risks of side effects like cramping and bleeding. Using misosprostol without mifepristone is also somewhat less effective at ending a pregnancy.
The FDA is arguing in the case that it has rigorously reviewed the safety and effectiveness of mifepristone as it has repeatedly reaffirmed its authorization of the drug in the past 23 years, and said in a court filing that revoking its approval would "cause significant harm, depriving patients of a safe and effective drug that has been on the market for more than two decades."
Urgent. It's never been this bad.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission from the outset was simple. To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It’s never been this bad out there. And it’s never been this hard to keep us going. At the very moment Common Dreams is most needed and doing some of its best and most important work, the threats we face are intensifying. Right now, with just three days to go in our Spring Campaign, we're falling short of our make-or-break goal. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Can you make a gift right now to make sure Common Dreams not only survives but thrives? There is no backup plan or rainy day fund. There is only you. —Craig Brown, Co-founder |
Ahead of a major hearing scheduled for Wednesday in a closely watched case which could further limit abortion access across the United States, reproductive rights advocates and journalists are decrying what one attorney called a right-wing judge's "informal gag order... bordering on judicial misconduct."
U.S. District Court Judge Matthew Kacsmaryk is scheduled to preside over the first hearing in a case brought by right-wing group Alliance Defending Freedom (ADF) in Amarillo, Texas on Wednesday, with lawyers for the organization arguing that the Food and Drug Administration (FDA) should never have approved mifespristone for medication abortion use in 2000, and the U.S. Justice Department opposing that claim. ADF aims to force the FDA to revoke its approval.
As The Washington Post reported Saturday, the right-wing judge scheduled the hearing last Friday in a call with lawyers on both sides, and in what one expert called a "very irregular" move, directed the attorneys to keep the hearing under wraps in order to minimize the possibility of protests.
Kacsmaryk also said he would delay putting the hearing on the public court docket, as judges usually do to keep the public and media informed about developments. He indicated he would make the hearing public knowledge only on Tuesday evening, making it difficult for Texans and members of the media to travel to Amarillo from other parts of the state and country. The city is a five-and-a-half hour drive from Dallas, the closest major Texas city; a nearly four-hour drive from Oklahoma City; and served by few daily direct flights.
At Law Dork, journalist Chris Geidner pointed out that Kacsmaryk violated the requirements he claims to uphold in his own courtroom. The "Judge Specific Requirements" on his page at the website for the U.S. District Court for the Northern District of Texas include that Kacsmaryk "heavily disfavor[s] sealing information placed in the judicial record."
"Going further, Kacsmaryk's requirements highlight the U.S. Court of Appeals for the 5th Circuit's rulings that recognize 'the public's right to know' about what's going on in our courts, requiring litigants to explain—with signed declarations—why 'the risks of disclosure' would 'outweigh' that right of the public to know what's happening in court," noted Geidner. "In order to even consider sealing anything on his docket, Kacsmaryk requires litigants to 'explain that no other viable alternative to sealing exists.'"
Kacsmaryk said Friday on his call with the attorneys that he was requesting they keep information about the hearing secret "as a courtesy," but Geidner said on Saturday that he "in effect, if not in actuality, put a gag order on the parties."
"This is a civil case with huge national implications challenging public, some long-standing, government actions," tweeted Geidner. "The affirmative decision to hide public notification of a hearing set on Friday until Tuesday night explicitly to decrease the chances of the public learning of the hearing in an attempt to decrease public participation is so unacceptable it is simply not judicial behavior."
Following the hearing, Kacsmaryk could hand down a ruling at any time. A decision in favor of ADF would immediately force abortion clinics across the U.S. to shift to providing only surgical abortions—which account for fewer than half of abortions in the U.S. each year—or medication abortions using only misoprostol.
ADF has argued that the U.S. government ignored evidence of harmful side effects of mifepristone when it approved the drug in 2000, but medical experts say misoprostol-only abortions carry greater risks of side effects like cramping and bleeding. Using misosprostol without mifepristone is also somewhat less effective at ending a pregnancy.
The FDA is arguing in the case that it has rigorously reviewed the safety and effectiveness of mifepristone as it has repeatedly reaffirmed its authorization of the drug in the past 23 years, and said in a court filing that revoking its approval would "cause significant harm, depriving patients of a safe and effective drug that has been on the market for more than two decades."
- Reproductive Rights Advocates, House Dems Blast MAGA Judge's Move to Block Abortion Pills ›
- 'He Needs to Be Investigated': Abortion Case Judge Potentially Hid Law Review Article From Senate ›
Ahead of a major hearing scheduled for Wednesday in a closely watched case which could further limit abortion access across the United States, reproductive rights advocates and journalists are decrying what one attorney called a right-wing judge's "informal gag order... bordering on judicial misconduct."
U.S. District Court Judge Matthew Kacsmaryk is scheduled to preside over the first hearing in a case brought by right-wing group Alliance Defending Freedom (ADF) in Amarillo, Texas on Wednesday, with lawyers for the organization arguing that the Food and Drug Administration (FDA) should never have approved mifespristone for medication abortion use in 2000, and the U.S. Justice Department opposing that claim. ADF aims to force the FDA to revoke its approval.
As The Washington Post reported Saturday, the right-wing judge scheduled the hearing last Friday in a call with lawyers on both sides, and in what one expert called a "very irregular" move, directed the attorneys to keep the hearing under wraps in order to minimize the possibility of protests.
Kacsmaryk also said he would delay putting the hearing on the public court docket, as judges usually do to keep the public and media informed about developments. He indicated he would make the hearing public knowledge only on Tuesday evening, making it difficult for Texans and members of the media to travel to Amarillo from other parts of the state and country. The city is a five-and-a-half hour drive from Dallas, the closest major Texas city; a nearly four-hour drive from Oklahoma City; and served by few daily direct flights.
At Law Dork, journalist Chris Geidner pointed out that Kacsmaryk violated the requirements he claims to uphold in his own courtroom. The "Judge Specific Requirements" on his page at the website for the U.S. District Court for the Northern District of Texas include that Kacsmaryk "heavily disfavor[s] sealing information placed in the judicial record."
"Going further, Kacsmaryk's requirements highlight the U.S. Court of Appeals for the 5th Circuit's rulings that recognize 'the public's right to know' about what's going on in our courts, requiring litigants to explain—with signed declarations—why 'the risks of disclosure' would 'outweigh' that right of the public to know what's happening in court," noted Geidner. "In order to even consider sealing anything on his docket, Kacsmaryk requires litigants to 'explain that no other viable alternative to sealing exists.'"
Kacsmaryk said Friday on his call with the attorneys that he was requesting they keep information about the hearing secret "as a courtesy," but Geidner said on Saturday that he "in effect, if not in actuality, put a gag order on the parties."
"This is a civil case with huge national implications challenging public, some long-standing, government actions," tweeted Geidner. "The affirmative decision to hide public notification of a hearing set on Friday until Tuesday night explicitly to decrease the chances of the public learning of the hearing in an attempt to decrease public participation is so unacceptable it is simply not judicial behavior."
Following the hearing, Kacsmaryk could hand down a ruling at any time. A decision in favor of ADF would immediately force abortion clinics across the U.S. to shift to providing only surgical abortions—which account for fewer than half of abortions in the U.S. each year—or medication abortions using only misoprostol.
ADF has argued that the U.S. government ignored evidence of harmful side effects of mifepristone when it approved the drug in 2000, but medical experts say misoprostol-only abortions carry greater risks of side effects like cramping and bleeding. Using misosprostol without mifepristone is also somewhat less effective at ending a pregnancy.
The FDA is arguing in the case that it has rigorously reviewed the safety and effectiveness of mifepristone as it has repeatedly reaffirmed its authorization of the drug in the past 23 years, and said in a court filing that revoking its approval would "cause significant harm, depriving patients of a safe and effective drug that has been on the market for more than two decades."
- Reproductive Rights Advocates, House Dems Blast MAGA Judge's Move to Block Abortion Pills ›
- 'He Needs to Be Investigated': Abortion Case Judge Potentially Hid Law Review Article From Senate ›